BMAP-27

General Information


DRACP ID  DRACP03506

Peptide Name   BMAP-27

Sequence  GRFKRFRKKFKKLFKKLSPVIPLLHL

Sequence Length  26

UniProt ID  B9UKM4  B9UKM3  P54228 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  2KET 

Predicted Structure  DRACP03506

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C158H262N44O28

Absent amino acids  ACDEMNQTWY

Common amino acids  K

Mass  367218

Pl  12.84

Basic residues  11

Acidic residues  0

Hydrophobic residues  11

Net charge  11

Boman Index  -4525

Hydrophobicity  -36.54

Aliphatic Index  101.15

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31226350

Title  Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide

Doi Not available

Year  2019

Literature 2

Pubmed ID 29882774

Title  Influence of Bacterial Biofilm Polysaccharide Structure on Interactions with Antimicrobial Peptides: A Study on Klebsiella pneumoniae

Doi Not available

Year  2018

Literature 3

Pubmed ID 19845398

Title  Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5973

DRACP is developed by Dr.Zheng's team.